The Centers for Disease Control and Prevention Sept. 5 alerted clinicians to a recent increase in respiratory syncytial virus in the Southeastern U.S., which could signal the beginning of 2023-2024 RSV season nationally. CDC encourages clinicians to prepare to implement prevention options, including the new long-acting monoclonal antibody to protect infants and some young children at higher risk for severe disease and two new vaccines to protect older adults from severe disease. 

Related News Articles

Headline
Kittitas Valley Healthcare in rural Washington state last year implemented an innovative new model for retaining essential obstetric and other women’s health…
Blog
Since 2018, Black Maternal Health Week has been a national observance from April 11–17. This annual observance was created by the Black Mamas Matter Alliance…
Headline
Two caregivers discuss how Colorado’s San Luis Valley Hospital creatively maximizes its resources to continue to deliver obstetric services to the families and…
Headline
As part of a yearlong series devoted to rural hospitals and health systems in America, two experts from Intermountain Health discuss their "First 1,000 Days of…
Headline
The House March 5 voted 382-12 to pass the AHA-supported Preventing Maternal Deaths Reauthorization Act (H.R. 3838), bipartisan legislation that would…
Headline
The House Energy and Commerce Subcommittee on Health Feb. 29 held a hearing on legislative proposals to expand access to treatment for patients with rare…